LSLotta Selin

Lotta Selin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lotta Selin has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Marie Berg

    Institute of Health and Care Sciences Sahlgrenska Academy Gothenburg Sweden

    4 shared publications
  • Gunnar Wallin

    University of Gothenburg, Department of Obstetrics and Gynecology, Institute for Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden

    3 shared publications
  • Elisabeth Almström

    NU-Hospital Group, Department of Obstetrics and Gynecology, Trollhättan, Sweden

    2 shared publications
  • Anna Dencker

    Institute of Health and Care Sciences Sahlgrenska Academy Gothenburg Sweden

    1 shared publication
  • Anna Dencker

    Institute of Health and Care Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden

    1 shared publication
  • Eva Wiberg-Itzel

    Department of Clinical Science and Education, Karolinska Institute, Soder Hospital

    1 shared publication

Latest Publications

  • Open Access

    Parents and newborn “togetherness” after birth

    by Katarina Patriksson, Lotta Selin

    Zero separation is a family-centred approach where newborns should be accompanied by their parents, regardless of the type of birth or health status. To our knowledge, few studies have described th...


  • Open Access

    Dosage of oxytocin for augmentation of labor and women’s childbirth experiences: A randomized controlled trial

    by Lotta Selin, Marie Berg, Ulla‐Britt Wennerholm, Anna Dencker

    Introduction: The aim of this study was to compare childbirth experiences and experience of labor pain in primiparous women who had received high‐ vs low‐dose oxytocin for augmentation of delayed labor.Material and methods: A multicenter, parallel, double‐blind randomized controlled trial took place in six Swedish labor wards. Inclusion criteria were healthy primiparous women at term with uncomplicated singleton pregnancies, cephalic fetal presentation, spontaneous onset of labor, confirmed delayed labor progress and ruptured membranes. The randomized controlled trial compared high‐ vs low‐dose oxytocin used for augmentation of a delayed labor progress. The Childbirth Experience Questionnaire version 2 (CEQ2) was sent to the women 1 month after birth. The CEQ2 consists of 22 items in four domains: Own capacity, Perceived safety, Professional support and Participation. In addition, labor pain was reported with a visual analog scale (VAS) 2 hours postpartum and 1 month after birth. The main outcome was the childbirth experience measured with the four domains of the CEQ2. The clinical trial number is NCT01587625.Results: The CEQ2 was sent to 1203 women, and a total of 1008 women (83.8%) answered the questionnaire. The four domains of childbirth experience were scored similarly in the high‐ and low‐dose oxytocin groups of women: Own capacity (P = .36), Perceived safety (P = .44), Professional support (P = .84), Participation (P = .49). VAS scores of labor pain were reported as similar in both oxytocin dosage groups. Labor pain was scored higher 1 month after birth compared with 2 hours postpartum. There was an association between childbirth experiences and mode of birth in both the high‐ and low‐dose oxytocin groups.Conclusions: Different dosage of oxytocin for augmentation of delayed labor did not affect women’s childbirth experiences assessed through CEQ2 1 month after birth, or pain assessment 2 hours or 1 month after birth.


  • Open Access

    High-dose versus low-dose of oxytocin for labour augmentation: a randomised controlled trial

    by Lotta Selin, Ulla-Britt Wennerholm, Maria Jonsson, Anna Dencker, Gunnar Wallin, Eva Wiberg-Itzel, Elisabeth Almström, Max Petzold, Marie Berg


  • Open Access

    Use and abuse of oxytocin for augmentation of labor

    by Lotta Selin, Elisabeth Almström, Gunnar Wallin, Marie Berg

    Objective. To investigate the use of oxytocin for augmentation of labor and its relation to labor progress and delivery outcome. Design and setting. A retrospective observational study undertaken in a Swedish hospital during 2000–2001. Sample. Singleton pregnancies at ≥ 37 weeks of gestation with cephalic presentation and spontaneous onset of labor. Methods. Data were collected from 1,263 clinical records. The partogram was used to diagnose labor dystocia (LD). Main outcome measures. Prevalence of oxytocin administration, LD and operative delivery. Results. Oxytocin was administered to 55% of the women (75% of primiparas and 38.1% of multiparas); a majority did not meet LD criteria. LD frequency was 19.8% (32.7% in primiparas and 7.4% in multiparas). Oxytocin was started both ‘too early’ and ‘too late’ in relation to the diagnosis of LD. Cesarean section (CS) was performed on 17.1% of primiparous and 2.4% of multiparous oxytocin recipients with LD, compared to 2.3 and 1.5%, respectively, of oxytocin recipients without diagnosed LD. Conclusions. Oxytocin augmentation was undertaken in an unstructured manner; some women were inadequately treated and others were treated unnecessarily. Oxytocin recipients with LD underwent operative delivery to a higher extent than oxytocin recipients without LD, suggesting that the main reason for CS was the underlying problem of LD rather than the oxytocin augmentation itself.


  • Dystocia in labour – risk factors, management and outcome: a retrospective observational study in a Swedish setting

    by Lotta Selin, Gunnar Wallin, Marie Berg

    Background. Labour dystocia (LD) is associated with adverse maternal and child outcomes. This study investigated obstetric risk factors, frequency of interventions and delivery outcomes for LD. Methods. A retrospective, observational, study of 1,480 deliveries was undertaken in a Swedish district hospital during 2000 and 2001. Results. LD was identified in 21% of deliveries, 16.7% of which ended in caesarean section (CS) compared to 1.7% of deliveries without LD. Multiparity with no previous vaginal delivery (OR = 6.0), epidural analgesia (EDA) at cervical dilation ≤5 cm (OR = 4.6), primiparity (OR = 4.5), gestational age ≥42 weeks (OR = 3.1), birth weight >4,000 g (OR = 2.7) and EDA at cervical dilation >5 cm (OR = 2.0) were major independent risk factors for LD. Conclusions. In delivery management, special attention should be directed to primiparous women and multiparous women with no previous vaginal delivery. Women given EDA, especially at cervical dilation ≤5 cm are also of particular interest. Furthermore, rigorous routines for LD diagnosis and oxytocin augmentation are important.